LEADER 01419nas  2200505-a 450 
001 996205872603316
005 20230213213019.0
011   $a1532-2785
035   $a(DE-599)ZDB2002474-5
035   $a(OCoLC)41401725
035   $a(CKB)954922647087
035   $a(CONSER)---00213140-
035   $a(EXLCZ)99954922647087
100   $a19990520a19809999  s--            a
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNeuropeptides
210   $aEdinburgh ;$aNew York $cChurchill Livingston
300   $aTitle from contents screen (ScienceDirect, viewed Nov. 14, 2005).
300   $aPublished: Elsevier Science Ltd., 2003-
311   $a0143-4179 
531   $aNEUROPEPTID
531   $aNEUROPEPTIDES HARLOW
531 0 $aNeuropeptides
606   $aNeuropeptides$vPeriodicals
606   $aNeuropeptides
606   $aNeuropeptides
606   $aNeuropeptides$vPériodiques
606   $aNeuropeptides
606   $aNeuropeptides$2fast$3(OCoLC)fst01036450
608   $aPeriodicals.$2fast
615  0$aNeuropeptides
615  0$aNeuropeptides.
615  2$aNeuropeptides
615  6$aNeuropeptides
615  6$aNeuropeptides.
615  7$aNeuropeptides.
676   $a572
906   $aJOURNAL
912   $a996205872603316
996   $aNeuropeptides$91429025
997   $aUNISA